NCT01476345View on ClinicalTrials.gov

A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY2963016 to Lantus in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Diabetes Mellitus
Interventions
DRUG

LY2963016

Administered subcutaneously

DRUG

Lantus

Administered subcutaneously

Trial Locations (1)

9301

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bloemfontein

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01476345 - A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY2963016 to Lantus in Healthy Participants | Biotech Hunter | Biotech Hunter